Dapagliflozin vs Gefitinib

Dapagliflozin vs Gefitinib: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Gefitinib.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Gefitinib — 48 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Gefitinib — C22H24ClFN4O3.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Gefitinib — 446.9000 g/mol.

Type: Dapagliflozin — Small molecule; Gefitinib — Small molecule.